drugset / Trial / NCT03393247

The Therapy Effect of Azathioprine Initial or 14 Weeks After Combined With Infliximab on CD

NCT03393247

RandomizedParallel-groupOpen-labelTreatment

Summary

This study aim to identify the therapeutic effect of azathioprine during infliximab(IFX) treatment in Crohn's disease (CD).Half of patients will receive azathioprine and infliximab combination therapy at the same time. The other half patients will be given infliximab therapy first and then receive azathioprine 14 weeks later.

Timeline

Start
2017-06-01
Primary completion
2018-07-01
Completion
2019-07-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azathioprine Small molecule
Comparator Infliximab Monoclonal antibody 5 mg/kg

Indications